// App-Quantinova.ai

351.0 : Survival and cost associated with chemotherapy and chemoradiotherapy among resected pancreas cancer patients.

Researchers

Presenter

  • Nivethan Vela

Principal Investigators

  • Laura Davis

  • Stephanie Y Cheng

  • Ahmed Hammad

  • Ying Liu

  • Daniel Kagedan

  • Lev Bubis

  • Craig Earle

  • Lawrence Frank Paszat

  • Sten Myrehaug

  • Alyson L. Mahar

  • Nicole Mittmann

  • Natalie G. Coburn

Medical Centers

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Sunnybrook Research Institute, Toronto, ON, Canada

  • Institute of Clinical Evaluative Sciences, Toronto, ON, Canada

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • HOPE Research Centre, Sunnybrook Hospital, Toronto, ON, Canada

  • Sunnybrook Health Sciences Centre and Odette Cancer Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A